Biomedical subjects

M Hernández Rodríguez

Publications and source records attributed to M Hernández Rodríguez.

8 recordsLinked to original sources

PubMed1999

[Incidence of epilepsy and epileptic syndromes in children in the province of Albacete].

OBJECTIVE: The purpose of this study was to determine the incidence rate and the relative frequency of epilepsy and epileptic syndromes during childhood in the province of Albacete. PATIENTS AND METHODS: Patients with childhood epilepsy living in the area have been diagnosed in the Neuropediatric Unit at the General Hospital of Albacete. We included patients under 11 years of age with unprovoked recurring epileptic seizures whose first seizure happened between 1-1-1987 and 1-12-1991, excluding those who have only suffered from febrile seizures and other provoked epileptic seizures. RESULTS: In the five-year period of the study, 136 patients from a population of 60,000 children under 11 years of age suffered from epilepsy. The annual incidence rate of epilepsy at this age is 45 in 100,000. For those under 1 year it is 113, for those aged 1 to 5 it is 52, and for those between 6 and 10 years 30. The most common epileptic syndrome is benign childhood epilepsy with centrotemporal spikes (29%), followed by undefined generalized idiopathic epilepsy (16%), symptomatic partial epilepsy (15%) and childhood absence epilepsy (9%). CONCLUSIONS: The epilepsy incidence rates reported here are lower than those found in most studies. Nevertheless, these results agree with some more recent studies. Benign childhood epilepsy with centrotemporal spikes is the most frequent epileptic syndrome during childhood.

Age Distribution↗

PubMed1996

[Primary hyperlipidemia in children and adolescents: effects of dietary and pharmacological intervention].

A retrospective study was performed on children with hypercholesterolemia or hypertriglyceridemia referred to the Endocrine Clinic of the Niño Jesús University Hospital over a period of 5 years. One hundred twenty-seven children, from 2 to 16 years of age, were followed. The subjects were classified into the following groups: 90 with primary hyperlipidemia [55 polygenic hypercholesterolemia (PH), 23 familial hypercholesterolemia (FH) and 12 with familial combined hyperlipidemia (FCH)]; 2 with secondary hypercholesterolemia and 35 were found to have normal cholesterol and triglyceride values. All patients with primary hyperlipoproteinemia were instructed to carry out dietary intervention during a 6 month period, following the step I recommendations of the National Cholesterol Education Program (NCEP). The following results were obtained: In the group of children with PH and FH a decrease in total and LDL cholesterol was observed (p < 0.0001 for both groups). In the group of FH, a decrease in the LDL/HDL ratio was also observed (p < 0.01). In contrast, the group of children with FCH did not show any changes in the lipoprotein pattern after dietary intervention. In the three groups studied, no statistically significant differences were observed in the remaining parameters (HDL-C, VLDL, and apo A1) after dietary intervention. Lp(a) levels above 30 mg/dl were observed in 25%, 37% and 46% of the children with PH, FH and FCH, respectively. Nine patients with FH were treated with resins for 3 months. In these children a decrease in total and LDL cholesterol, apo B and in the LDL/HDL ratio was observed (p < 0.05). No changes in Lp(a) and HDL-C were observed in this group of children. In our experience, dietary intervention to reduce fat and cholesterol intake in children with primary hyperlipoproteinemia, a population at high risk of developing atherosclerosis, is safe and useful. The treatment with resins in children with FH improves their lipoprotein profile.

Adolescent↗

PubMed1992